TG Therapeutics, Inc.
TGTX
$29.45
$0.6752.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.19M | 5.06M | 23.33M | 3.88M | 6.88M |
| Total Depreciation and Amortization | 13.00K | 8.00K | 9.00K | 11.00K | 19.00K |
| Total Amortization of Deferred Charges | 350.00K | 352.00K | 356.00K | 467.00K | 692.00K |
| Total Other Non-Cash Items | 15.63M | 14.41M | 11.40M | 15.26M | 8.61M |
| Change in Net Operating Assets | -36.74M | -48.54M | -60.74M | -31.83M | -10.67M |
| Cash from Operations | 7.44M | -28.72M | -25.64M | -12.21M | 5.54M |
| Capital Expenditure | -42.00K | -25.00K | -21.00K | -24.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.95M | -12.91M | 15.81M | -9.31M | 1.77M |
| Cash from Investing | -3.99M | -12.93M | 15.79M | -9.33M | 1.77M |
| Total Debt Issued | -- | -- | 0.00 | 244.82M | -- |
| Total Debt Repaid | -- | -- | 0.00 | -107.55M | -- |
| Issuance of Common Stock | 432.00K | 21.00K | 570.00K | 199.00K | 135.00K |
| Repurchase of Common Stock | -6.88M | -6.12M | -6.61M | -2.15M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -31.00K | -858.00K | -- |
| Cash from Financing | -6.44M | -6.10M | -6.07M | 134.45M | 135.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.00M | -47.75M | -15.93M | 112.92M | 7.44M |